Skip to main content
AEMD logo

AEMD · Aethlon Medical Inc · Executive Compensation

Track AEMD — free
$4.84 -0.27 (-5.28%) Play latest call Q3 2026 earnings call transcript
Market Cap
$7.78M
Shares
1.61M
Volume · Nov 19 20.26K Avg daily vol (3M) 2.52M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2026
Executive Total
James B. Frakes $826,922
Steven P. LaRosa $593,480
Guy F. Cipriani $211,250
Fiscal 2025
Executive Total
James B. Frakes $500,000
Steven P. LaRosa $480,000
Guy F. Cipriani $395,688
Fiscal 2024
Executive Total
Charles J. Fisher, Jr. $505,332
Charles Fisher $505,332
Steven P. LaRosa $430,000
James B. Frakes $416,449
Guy F. Cipriani $378,064
Fiscal 2023
Executive Total
Charles J. Fisher, Jr. $460,000
Charles Fisher $460,000
Steven P. LaRosa $430,000
Guy F. Cipriani $347,500
Fiscal 2022
Executive Total
Charles J. Fisher, Jr. $2,477,896
Charles Fisher $2,477,896
Steven P. LaRosa $792,614
Guy F. Cipriani $772,880
Fiscal 2021
Executive Total
Timothy C., Rodell $862,563
James B. Frakes $581,661
Steven P. LaRosa $480,449
Charles J. Fisher, Jr. $474,941
Charles Fisher $474,941
Fiscal 2020
Executive Total
Timothy C., Rodell $595,000
James B. Frakes $354,750
Fiscal 2019
Executive Total
Timothy C., Rodell $729,138
James B. Frakes $285,833

Executive changes

Person Change Filed
Chetan S. Shah, MD Appointed 2026-10-01
Angela Rossetti Appointed 2026-10-01
Nicolas Gikakis Appointed 2026-10-01
James B. Frakes Appointed 2026-10-01
Edward G. Broenniman Appointed 2026-10-01
Angela Rossetti Appointed 2026-02-23
Chetan S. Shah, MD Appointed 2026-02-23
Nicolas Gikakis Appointed 2026-02-23
James B. Frakes Appointed 2026-02-23
Edward G. Broenniman Appointed 2026-02-23
James B. Frakes Appointed 2024-10-03
Chetan S. Shah, MD Appointed 2024-10-02
Angela Rossetti Appointed 2024-10-02
James B. Frakes Appointed 2024-10-02
Nicolas Gikakis Appointed 2024-10-02
Edward G. Broenniman Appointed 2024-10-02
Charles J. Fisher, Jr., M.D. Resigned 2023-11-27
Guy F. Cipriani Appointed 2023-11-13
James B. Frakes Appointed 2023-11-13
James B. Frakes Appointed 2023-11-13
Guy F. Cipriani Resigned 2023-11-13
Nicolas Gikakis Appointed 2023-07-06
Chetan S. Shah, MD Appointed 2022-09-19
Charles J. Fisher, Jr., MD Appointed 2022-09-19
Guy F. Cipriani Appointed 2022-09-19

Leadership

Key facts CIK 882291 CUSIP 00808Y703 13F (30d) 16 filings 16 filers Visit website Investor relations